More about

Age-Related Macular Degeneration

News
July 09, 2024
1 min read
Save

Melatonin use associated with lower risk for AMD development, progression in older adults

Melatonin use associated with lower risk for AMD development, progression in older adults

Melatonin use was associated with a decreased risk for both development and progression of age-related macular degeneration among adults aged 50 years or older, according to a study published in JAMA Ophthalmology.

News
July 08, 2024
4 min read
Save

BLOG: Optometrists, retina specialists, industry work together to slow progression of GA

BLOG: Optometrists, retina specialists, industry work together to slow progression of GA

Age-related macular degeneration is the leading cause of vison loss among older adults.

News
July 07, 2024
2 min watch
Save

VIDEO: Astellas offers updates on Izervay safety, phase 1 geographic atrophy trial

VIDEO: Astellas offers updates on Izervay safety, phase 1 geographic atrophy trial

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Carolyn Sasse of Astellas highlights the company’s ophthalmology pipeline.

News
July 01, 2024
1 min watch
Save

VIDEO: Individuals with AMD indicate interest in bionic vision options

VIDEO: Individuals with AMD indicate interest in bionic vision options

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, discusses a presentation at the ARVO annual meeting on patient preferences for retinal prosthesis options.

News
June 27, 2024
1 min watch
Save

VIDEO: Regenxbio offers updates on ABBV-RGX-314 programs

VIDEO: Regenxbio offers updates on ABBV-RGX-314 programs

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Steve Pakola, MD, chief medical officer of Regenxbio, shares updates on the company’s retina programs.

News
June 25, 2024
1 min watch
Save

VIDEO: Notal Vision celebrates FDA authorization of AI-powered Scanly Home OCT device

VIDEO: Notal Vision celebrates FDA authorization of AI-powered Scanly Home OCT device

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Kester Nahen, PhD, CEO of Notal Vision, discusses the patient self-operated AI-powered Scanly Home OCT device.

News
June 24, 2024
2 min watch
Save

VIDEO: Choroidal macrophages could be target for AMD treatments

VIDEO: Choroidal macrophages could be target for AMD treatments

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, continues to discuss highlights from the ARVO annual meeting.

News
June 13, 2024
1 min watch
Save

VIDEO: Data show positive effect of Axpaxli for wet AMD at 36 weeks

VIDEO: Data show positive effect of Axpaxli for wet AMD at 36 weeks

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Anat Loewenstein, MD, of Tel Aviv Medical Center in Israel, discusses Axpaxli for the treatment of neovascular age-related macular degeneration.

News
June 12, 2024
2 min watch
Save

VIDEO: COAST, ShORe trials aim to replicate superiority demonstrated in phase 2b trial

VIDEO: COAST, ShORe trials aim to replicate superiority demonstrated in phase 2b trial

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Fred Guerard, CEO of Opthea, shares updates on the COAST and ShORe trials.

News
June 12, 2024
1 min watch
Save

VIDEO: Better understanding of Bruch’s membrane may help development of AMD treatments

VIDEO: Better understanding of Bruch’s membrane may help development of AMD treatments

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, discusses how targeting abnormalities in Bruch’s membrane in patients with age-related macular degeneration may aid in the development of treatments.

View more